Veronika Navrkalová, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2017

• Kantorova, B; Malcikova, J; Brazdilova, K; Borsky, M; Plevova, K; Smardova, J; Radova, L; Tom, N; Trbusek, M; Diviskova, E; Francova, HS; Navrkalova, V; Doubek, M; Brychtova, Y; Mayer, J; Pospisilova, S, 2017: Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY 178(6), p. 979 - 982, doi: 10.1111/bjh.14176
• Kafkova, LR; Navrkalova, V; Jarosova, M; Loja, T; Chovancova, J; Kucerova, J; Kriegova, E; Prochazka, V; Novak, Z; Simkova, D; Pospisilova, S; Divoky, V, 2017: Ability to downregulate the level of cyclin-dependent kinase inhibitor p27(Kip1) after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway. LEUKEMIA & LYMPHOMA 58(1), p. 199 - 203, doi: 10.1080/10428194.2016.1187276

2016

• Navrkalova, V; Young, E; Baliakas, P; Radova, L; Sutton, LA; Plevova, K; Mansouri, L; Ljungstrom, V; Ntoufa, S; Davis, Z; Juliusson, G; Smedby, KE; Belessi, C; Panagiotidis, P; Touloumenidou, T; Davi, F; Langerak, AW; Ghia, P; Strefford, JC; Oscier, D; Mayer, J; Stamatopoulos, K; Pospisilova, S; Rosenquist, R; Trbusek, M, 2016: ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. HAEMATOLOGICA 101(9), doi: 10.3324/haematol.2016.142968

2015

• Zemanova, J; Paruch, K; Krejci, L; Soucek, K; Hylse, O; Boudny, M; Borsky, M; Osickova, J; Khirsariya, P; Sebejova, L; Navrkalova, V; Malcikova, J; Diviskova, E; Brychtova, Y; Mayer, J; Trbusek, M, 2015: CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE HIGHLY SUSCEPTIBLE TO DIRECT INHIBITION OF CHECKPOINT KINASE 1. HAEMATOLOGICA 100, p. 417 - 417
• Navrkalova, V; Kafkova, LR; Divoky, V; Pospisilova, S, 2015: Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients. HAEMATOLOGICA 100(8), p. 994 - 996, doi: 10.3324/haematol.2015.130260
• Noerenberg, D; Young, E; Ljungstrom, V; Mansouri, L; Plevova, K; Baliakas, P; Blakemore, S; Rossi, D; Clifford, R; Navrkalova, V; Sutton, LA; Smedby, KE; Juliusson, G; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Schuh, A; Gaidano, G; Strefford, JC; Ghia, P; Stamatopoulos, K; Pospisilova, S; Zenz, T; Rosenquist, R; Damm, F, 2015: EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player. BLOOD 126(23)
• Navrkalova, V; Young, E; Baliakas, P; Radova, L; Plevova, K; Sutton, LA; Mansouri, L; Ljungstrom, V; Ntoufa, S; Davis, Z; Juliusson, G; Smedby, KE; Belessi, C; Panagiotidis, P; Davi, F; Langerak, AW; Ghia, P; Strefford, JC; Oscier, DG; Stamatopoulos, K; Pospisilova, S; Rosenquist, R; Trbusek, M, 2015: ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome. BLOOD 126(23)
• Young, E; Norenberg, D; Ljungstrom, V; Mansouri, L; Plevova, K; Baliakas, P; Rossi, D; Navrkalova, V; Sutton, LA; Smedby, KE; Juliusson, G; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Gaidano, G; Ghia, P; Stamatopoulos, K; Pospisilova, S; Zenz, T; Rosenquist, R; Damm, F, 2015: EGR2 mutations in chronic lymphocytic leukemia- a new bad player?. LEUKEMIA & LYMPHOMA 56, p. 83 - 85
• Baliakas, P; Hadzidimitriou, A; Sutton, LA; Rossi, D; Minga, E; Villamor, N; Larrayoz, M; Kminkova, J; Agathangelidis, A; Davis, Z; Tausch, E; Stalika, E; Kantorova, B; Mansouri, L; Scarfo, L; Cortese, D; Navrkalova, V; Rose-Zerilli, MJJ; Smedby, KE; Juliusson, G; Anagnostopoulos, A; Makris, AM; Navarro, A; Delgado, J; Oscier, D; Belessi, C; Stilgenbauer, S; Ghia, P; Pospisilova, S; Gaidano, G; Campo, E; Strefford, JC; Stamatopoulos, K; Rosenquist, R, 2015: Recurrent mutations refine prognosis in chronic lymphocytic leukemia. LEUKEMIA 29(2), p. 329 - 336, doi: 10.1038/leu.2014.196
• te Raa, GD; Derks, IAM; Navrkalova, V; Skowronska, A; Moerland, PD; van Laar, J; Oldreive, C; Monsuur, H; Trbusek, M; Malcikova, J; Loden, M; Geisler, CH; Hullein, J; Jethwa, A; Zenz, T; Pospisilova, S; Stankovic, T; van Oers, MHJ; Kater, AP; Eldering, E, 2015: The impact of SF3B1 mutations in CLL on the DNA-damage response. LEUKEMIA 29(5), p. 1133 - 1142, doi: 10.1038/leu.2014.318
• te Raa, GD; Moerland, PD; Leeksma, AC; Derks, IA; Yigittop, H; Laddach, N; Loden-van Straaten, M; Navrkalova, V; Trbusek, M; Luijks, DM; Zenz, T; Skowronska, A; Hoogendoorn, M; Stankovic, T; van Oers, MH; Eldering, E; Kater, AP, 2015: Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification. CELL DEATH & DISEASE 6, doi: 10.1038/cddis.2015.223
• Sutton, LA; Ljungstrom, V; Mansouri, L; Young, E; Cortese, D; Navrkalova, V; Malcikova, J; Muggen, AF; Trbusek, M; Panagiotidis, P; Davi, F; Belessi, C; Langerak, AW; Ghia, P; Pospisilova, S; Stamatopoulos, K; Rosenquist, R, 2015: Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting. HAEMATOLOGICA 100(3), p. 370 - 376, doi: 10.3324/haematol.2014.109777

• Vývoj modulární bioinformatické platformy pro analýzu dat získaných sekvenováním nové generace, , 2019 - 2021